Real-world use of ixekizumab for axial spondyloarthritis treatment in Spain (ESPADA study).

Front Med (Lausanne) · 2025 · PMC12827647 · PMID 41585216

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although slight downward trends were observed during follow-up in other activity indices (DAS-28, TJC, and SJC) among patients with peripheral involvement, these results did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.